National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1954. No..

 

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

Dated this  twenty-fourth

day of  June , 1954.

W. J. Slim

Governor-General.

By His Excellency’s Command,

SGD. EARLE PAGE.

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of July, 1954.

* Notified in the Commonwealth Gazette on , 1954.

  Statutory Rules 1954, No. 54, as amended by Statutory Rules 1954, No.

2797.—Price 3d.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting item 13 and inserting in its stead the following item :—
“ 13	Benzhexol. Hydrochloride	2 mg...........................................	tablet ..........................................	LB, ST	100	1
5 mg. ..........................................	tablet ..........................................	LE, ST	100	1 ”;
(b) by omitting item 83 and inserting in its stead the following item :—
“ 83	Insulin, Injection OF....................................................	20 U. per cc. ...............................	5 cc. vial ....................................	AH and BD, BW	3	12
20 U. per cc. ...............................	10 cc. vial ..................................	AH and BD, BW, CS	3	12
40 U. per cc. ...............................	5 cc. vial ....................................	AH and BD, BT, BW	3	12
40 U. per cc. ...............................	10 cc. vial ..................................	AH and BD, BT, BW, CS	3	12
60 U. per cc. ...............................	5 cc. vial ....................................	CS	3	12
80 U. per cc. ...............................	5 cc. vial ....................................	AH and BD, BT, BW, CS	3	12
80 U. per cc.	10 cc. vial ..................................	AH and BD, BT, BW, CS	3	12
100 U. per cc. .............................	5 cc. vial ....................................	CS	3	12 ”;
(c) by omitting item 88 and inserting in its stead the following item :—
“ 88	Insulin Protamine Zinc, Injection of................................................	40 U. per cc.	5 cc. vial ....................................	AH and BD, BT, BW	3	12
40 U. per cc. ...............................	10 cc. vial ..................................	AH and BD, BT, BW, CS	3	12
80 U. per cc. ...............................	5 cc. vial ....................................	AH and BD, BT, BW, CS	3	12
80 U. per cc. ...............................	10 cc. vial ..................................	CS	3	12 ”;
(d) by omitting item 121 and inserting in its stead the following item :—
“ 121	Papaverine Hydrochloride....................................................	⅓ gr. per cc. ...............................	1 cc. amp. ..................................	KL	6	..
1½ gr. per 5 cc. ...........................	5 cc. amp....................................	AN	6	..
2 gr. per 10 cc. ...........................	10 cc. amp. ................................	DH, HA, KL	6	..
¾ gr. ..........................................	tablet ..........................................	AN, KL, QE, RT	25	1
l½ gr. .........................................	tablet ..........................................	AN, DH, FA, HA, KL, QB, RT	25	1 ”;
(e) by omitting items 125, 126 and 127 and inserting in their stead the following items :—
“ 125	Penicillin, Injection of....................................................	5,000 U. .....................................	amp. ..........................................	CS	6	..
15,000 U. ...................................	amp............................................	CS	6	..
100,000 U. .................................	amp............................................	AH, BD, BT, CS, EV, GL, IC, SI	6	..
200,000 U. .................................	amp. ..........................................	AH, BD, BT, CS, EV, GL, IC, SI	6	...

 

“ 125	Penicillin, Injection of—	500,000 U. .................................	amp. ..........................................	AH, BD, BT, CS, DH, BV,	3	..
contd.	continued....................................................	GL, IC, SI
1,000,000 U. ..............................	amp. ..........................................	AH, BD, BT, CS, DH, BV, GL, IC, SI	1	..
1,500,000 U. ..............................	amp. ..........................................	GL	1	..
“ 126	Penicillin, Procaine, Aqueous	300,000 U.	amp. ..........................................	BT	3	..
Suspension of...................................................	400,000 U. .................................	vial ............................................	DH, PA	3	..
600,000 U. .................................	vial ............................................	BT, DH	2	..
900,000 U. .................................	vial ............................................	CS, DH, SI	2	..
1,000,000 U.	vial ............................................	DH, PA	1	..
1,500,000 U. ..............................	vial ............................................	CS, DH, PA, GL, SI	1	..
“ 127	Penicillin, Procaine (Crystalline), Injection of...............................................	300,000 U. .................................	amp. ..........................................	AH, BD, BT, BW, CS, DH, EV, IC, MB, SI	3	..
400,000 U. .................................	amp. ..........................................	AH, BD, BT, BW, CS, BV, GL, IC, MB, SI	3	..
500,000 U. .................................	amp. ..........................................	CS	3	..
600,000 U. .................................	amp. ..........................................	DH	2	..
667,000 U. .................................	amp. ..........................................	CS	2	..
900,000 U. .................................	amp. ..........................................	AH, BD, BT, BW, CS, BV, IC, MB, SI	2	..
1,200,000 U. ..............................	amp. ..........................................	AH, BD, BT, BW, CS, DH, EV, IC, MB, SI	1	..
1,500,000 U. ..............................	amp. ..........................................	CS, DH, GL, SI	1	..”;
(f) by omitting item 135 and inserting in its stead the following item :—
“ 135	Phemitone ...................................................	½ gr. ..........................................	tablet ..........................................	AS, BA, BT, PA, IC, QE, SI	100	1
1 gr. ...........................................	tablet ..........................................	AS, BA, IC, QE, SI	100	1
3gr. ............................................	tablet ..........................................	AS, BA, BT, PA, IC, QE, SI	100	1 ”;
and
(g) by omitting item, 183 and inserting in its stead the following item :—
“ 183	Theophylline with Ethylene...................................................	0.366 G. per 10 mil.....................	10 mil. amp. ...............................	AB	6	..
diamine...................................................	0.732 G. per 2 mil.......................	2 mil. amp. .................................	AB	6	..
0.48 G. per 2 mil.........................	2 mil. I.M. amp. ..........................	DH, HA	6	..
0.5 G. per 2 mil...........................	2 mil. I.M. amp. ..........................	AH, BW, CM	6	..
0.24 G. per 10 mil.......................	10 mil. I.V. amp. ........................	DH, HA	6	..

 

“ 183	Theophylline with ethylene-	0.25 G. per 10 mil.......................	10 mil. I.V. amp. ........................	AH, BW, CM	6	..
contd.	Diamine—continued......................................................	1½ gr. ........................................	tablet ..........................................	BT, BW, CM, DH, FA, HA, HY, KL, QE, RT, SI, SM	100	1
2.34 gr. ......................................	tablet ..........................................	AB	100	1 ”.

Second Schedule.

3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting item 13 and inserting in its stead the following item :—

“ 13	Isoniazid ......................................	50 mg.......................	tablet...............	AN, DH, HA, HT, HY, KL, MB, NS, QE, RO, SC, SI	100	1	Tuberculosis ”; and
100 mg.....................	tablet...............	MB, RO	100	1
(b) by omitting item 33 and inserting in its stead the following item :—
“ 33	Vitamin B12, Injection of...........	10γ per cc.................	1 cc. amp.........	BD, DH	12	1	Established megalocytic anaemias ”.
15γ per cc.................	1 cc. amp.........	PD	12	1
20γ per cc.................	1 cc. amp.........	AH, AN, BD, BL, BT, BW, CK, CM, DH, EV, GL, IC, KL, NS, SI, ST, VM	12	1
50γ per cc.................	1 cc. amp.........	AH, BD, BL, BT, BW, CK, DH, EV, GL, IC, NS, VM	6	1
100γ per cc. .............	1 cc. amp.........	AH, AN, BD, BL, BT, BW, CK, CM, DH, EV, GL, IC, KL, PD, SI, VM	1	1
100γ per cc...............	10 cc. vial........	CM	1	..
200γ per cc...............	1 cc. amp.........	BT	1	..
l,000γ per cc.............	1 cc. amp.........	AN, CM, DH, GL, KL	1	..
l,000γ per cc.............	10 cc. vial........	CM	1	..

Third schedule.

4. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by inserting after item 128 the following items :—

“ 128a	Tabellae Aminophyllinae gr. 1½ cum Phenobarbitoni gr. ½
“ 128b	Tabellae Ephedrinae gr. ½ cum Phenobarbitoni gr. ¼ ”;

(b) by inserting after item 132 the following item :—

“ 132a Tabellae Potassii Bromidi ”; and

(c) by inserting after item 133 the following item :—

“ 133a Tabellae Sodii Pentobarbitoni ”.

By Authority: L. F Johnston, Commonwealth Government Printer, Canberra.